Hypermobility Spectrum Disorder vs EDS - What You Need to Know

Get the lowdown on Hypermobility Spectrum Disorder vs EDS - everything you need to know about these complex conditions.

Understanding Hypermobility Disorders

Hypermobility disorders, such as hypermobile Ehlers-Danlos syndrome (EDS) and hypermobility spectrum disorders, are conditions characterized by symptomatic joint hypermobility. Hypermobile EDS is the most common variant of EDS, accounting for 80% to 90% of EDS cases [1]. These disorders are diagnosed by applying the 2017 diagnostic criteria, which exclude other less common conditions presenting with joint hypermobility, such as other forms of EDS and heritable connective tissue disorders.

Differentiating Between Disorders

The 2017 International Classification of the Ehlers-Danlos syndromes introduced the term "hypermobility spectrum disorders" for patients who do not meet the diagnostic criteria for hypermobile EDS. This classification helps differentiate between individuals with varying degrees of joint hypermobility and associated symptoms.

To distinguish between hypermobile EDS and hypermobility spectrum disorders, healthcare professionals evaluate the clinical features and apply the diagnostic criteria. Hypermobile EDS is characterized by joint hypermobility, skin findings, and joint pains or recurrent dislocations. Hypermobile EDS and, less commonly, hypermobility spectrum disorders may also be associated with extra-articular symptoms such as anxiety disorders, chronic pain, fatigue, orthostatic intolerance, functional gastrointestinal disorders, and pelvic and bladder dysfunction.

Signs and Symptoms

The signs and symptoms of hypermobility disorders can vary among individuals. Common manifestations include joint hypermobility, joint pains, recurrent joint dislocations, and skin findings. Additionally, individuals with hypermobile EDS or hypermobility spectrum disorders may experience various extra-articular symptoms, such as anxiety disorders, chronic pain, fatigue, orthostatic intolerance, functional gastrointestinal disorders, and pelvic and bladder dysfunction.

Diagnosing hypermobile EDS or hypermobility spectrum disorders involves a thorough medical history review, physical examination, and exclusion of other conditions that present with musculoskeletal hypermobility. The diagnosis is primarily clinical, as no specific confirmatory test exists. Laboratory testing and radiography may be conducted to evaluate for acquired connective tissue disorders or suspected bone or joint injuries based on clinical history and physical examination findings. Genetic testing may be necessary to rule out other EDS variants, Marfan and Loeys-Dietz syndromes, and other genetic conditions when suspected.

Early diagnosis and proper management of hypermobility disorders are crucial for optimizing patient outcomes and quality of life. By differentiating between hypermobile EDS and hypermobility spectrum disorders and recognizing their associated signs and symptoms, healthcare professionals can provide appropriate care and support to individuals affected by these conditions.

Diagnosis and Testing

When it comes to diagnosing hypermobility spectrum disorder (HSD) and Ehlers-Danlos syndrome (EDS), a comprehensive evaluation is essential. This involves a combination of clinical evaluation and, in some cases, genetic testing.

Clinical Evaluation

Clinical evaluation is a crucial step in diagnosing hypermobility disorders. A physician will assess the individual's medical history, perform a physical examination, and exclude other conditions that may present with musculoskeletal hypermobility [1]. During the physical examination, the physician will evaluate joint flexibility, as well as conduct skin and eye checks.

For hypermobile EDS, the diagnostic criteria listed in Figure 2 can be used, while for hypermobility spectrum disorders, when patients do not meet the criteria for hypermobile EDS or another specific condition, the criteria outlined in Table 1 can be considered [1]. Additionally, taking a detailed family history is crucial to inquire about joint hypermobility, musculoskeletal symptoms, aneurysms, and genetic conditions that may be present.

Genetic Testing

Genetic testing plays a role in confirming the diagnosis, particularly for rarer forms of EDS. However, for the most common form, hypermobile EDS, genetic testing is not available [2]. Therefore, the diagnosis for hypermobile EDS and hypermobility spectrum disorders remains primarily clinical, based on medical history, physical examination, and exclusion of other conditions.

In some cases, when there is suspicion of other EDS variants, Marfan syndrome, Loeys-Dietz syndrome, or other genetic conditions, specific genetic testing may be performed as guided by clinical history and physical examination. However, it's important to note that there is no confirmatory test available for hypermobile EDS and hypermobility spectrum disorders.

It's crucial to work closely with a healthcare professional experienced in diagnosing and managing hypermobility disorders to ensure an accurate diagnosis. Through a thorough clinical evaluation and, if necessary, genetic testing, individuals can receive the appropriate diagnosis and develop a suitable treatment plan to manage their condition effectively.

Treatment and Management

When it comes to managing hypermobility spectrum disorder (HSD) and Ehlers-Danlos syndrome (EDS), a comprehensive approach is necessary to address the various symptoms and challenges that individuals may face. Treatment options typically focus on alleviating pain, improving mobility, and preventing further complications. In this section, we will explore the common treatment and management strategies for HSD and EDS, including medications and pain control, physical therapy and exercise, as well as surgical interventions.

Medications and Pain Control

Pain management plays a crucial role in the treatment of HSD and EDS. While there is no cure for EDS, medications can help control pain and improve quality of life. Nonsteroidal anti-inflammatory drugs (NSAIDs) may be prescribed to reduce inflammation and relieve pain. In some cases, stronger pain medications, such as opioids, may be necessary for more severe pain [2].

It's important to work closely with a healthcare professional to determine the most appropriate medications and dosage based on individual needs. Regular communication with the healthcare team helps to monitor the effectiveness of the medications and make any necessary adjustments.

Physical Therapy and Exercise

Physical therapy and exercise are essential components of managing HSD and EDS. These interventions aim to strengthen muscles, stabilize joints, and improve overall mobility. A physical therapist can develop a customized exercise program tailored to the individual's specific needs and limitations.

Low-impact exercises, such as swimming, walking, and tai chi, can be particularly beneficial for individuals with HSD and EDS. Tai chi, in particular, has been shown to reduce falls and decrease pain in conditions like hypermobile EDS [3]. However, it's important to consult with a healthcare professional or physical therapist before starting any new exercise regimen to ensure safety and appropriateness.

Surgical Interventions

In some cases, surgical interventions may be necessary to address specific complications associated with HSD and EDS. For example, individuals with EDS may require surgical procedures to repair damaged joints or address ruptured areas in blood vessels and organs. The decision to undergo surgery is typically made in collaboration with a healthcare team, considering the severity of symptoms and potential risks and benefits.

Surgical interventions in HSD and EDS are specialized and may require the expertise of healthcare professionals with experience in managing these conditions. Close post-operative care and rehabilitation are crucial to optimize outcomes and minimize complications.

By utilizing a combination of medications, pain control techniques, physical therapy, exercise, and surgical interventions when necessary, individuals with HSD and EDS can effectively manage their symptoms and improve their quality of life. It's important to work closely with a healthcare team to develop a personalized treatment plan that addresses the specific needs and challenges associated with these conditions.

Lifestyle and Support

When it comes to managing hypermobility spectrum disorder (HSD) and Ehlers-Danlos syndrome (EDS), lifestyle adjustments and support play a crucial role in enhancing the well-being of individuals affected by these conditions. This section will explore the importance of psychological support and self-care strategies in promoting a better quality of life.

Psychological Support

Psychological support is an integral component of the comprehensive management approach for individuals with hypermobility spectrum disorder and EDS. These conditions can have a significant impact on mental health, and addressing the psychological aspects is essential for holistic care.

Cognitive-behavioral therapy (CBT) is a commonly recommended approach that can assist individuals with hypermobile EDS in managing symptoms and improving their overall well-being. CBT can help individuals develop coping strategies, address feelings of being a burden to others, and improve their mental resilience. Additionally, counseling sessions can provide a safe space to explore the emotional challenges associated with these conditions and offer support in navigating the complex physical and emotional experiences.

Self-Care Strategies

Self-care strategies are vital for individuals with hypermobility spectrum disorder and EDS to manage their symptoms and optimize their daily lives. Implementing self-care practices can empower individuals and enhance their quality of life.

Some self-care strategies that may be beneficial include:

  • Pacing: Understanding and respecting one's limits is crucial for managing symptoms. Pacing activities and allowing for adequate rest and recovery can help prevent overexertion and minimize the risk of joint injury.
  • Gentle exercise: Engaging in low-impact exercises, such as swimming or yoga, can help improve muscle strength, joint stability, and overall flexibility. However, it is important to consult with healthcare professionals to tailor exercise routines to individual capabilities and avoid activities that may exacerbate symptoms.
  • Joint protection: Employing techniques to protect the joints, such as using assistive devices, practicing proper body mechanics, and avoiding repetitive movements or positions that strain the joints, can help minimize pain and reduce the risk of injury.
  • Stress management: Effective stress management techniques, such as relaxation exercises, mindfulness, and engaging in enjoyable activities, can help individuals cope with the challenges associated with hypermobility spectrum disorder and EDS.
  • Supportive aids and equipment: Utilizing assistive devices, such as braces or orthotics, can provide additional support and stability to joints, helping individuals manage day-to-day activities with greater ease.

Adopting self-care strategies tailored to individual needs and abilities can make a significant difference in managing symptoms, enhancing function, and improving overall well-being.

By prioritizing psychological support and implementing self-care strategies, individuals with hypermobility spectrum disorder and EDS can navigate the challenges associated with these conditions and lead fulfilling lives. It is essential to work closely with healthcare professionals, including physical therapists, occupational therapists, and counselors, to develop personalized care plans and ensure comprehensive support [4]. With the right support system in place, individuals can better manage their symptoms and optimize their quality of life.

Prognosis and Outlook

Understanding the prognosis and long-term outlook for individuals with hypermobility spectrum disorder (HSD) and Ehlers-Danlos syndrome (EDS) is essential for managing these conditions effectively.

Long-Term Outlook

The long-term outlook for individuals with HSD and EDS can vary depending on the specific subtype and severity of the condition. HSD is generally considered less severe than EDS, but both can pose significant challenges and potential complications.

While HSD may present with joint hypermobility and related symptoms, it is important to note that symptoms of HSD may resolve with therapy, persist, or progress to hypermobile EDS. It is crucial for individuals with HSD to receive appropriate medical care and monitoring to address any potential progression or development of additional symptoms.

EDS, especially the hypermobile subtype, is typically more severe and can lead to serious issues with the eyes, blood vessels, or heart. Individuals with hypermobile EDS may require additional testing and specialized care to manage and monitor these potential complications.

It is important for individuals with HSD and EDS to work closely with healthcare professionals, including specialists familiar with these conditions, to develop a comprehensive management plan. Regular monitoring, appropriate interventions, and self-care strategies can help improve the long-term outlook and quality of life for individuals with these hypermobility disorders.

Potential Complications

Both HSD and EDS can be associated with various complications and extra-articular symptoms. These may include anxiety disorders, chronic pain, fatigue, orthostatic intolerance, functional gastrointestinal disorders, and pelvic and bladder dysfunction. Individuals with HSD and EDS may also experience abdominal cramping, bloating, joint problems, skin healing problems, and other medical issues.

Managing these potential complications requires a multidisciplinary approach that addresses both physical and psychological aspects of the conditions. Treatment strategies may include medications for pain control, physical therapy and exercise to improve joint stability, and surgical interventions in certain cases. Psychological support plays a crucial role in helping individuals cope with the challenges associated with HSD and EDS.

By staying informed, actively managing symptoms, and seeking appropriate medical care, individuals with HSD and EDS can minimize potential complications and improve their overall quality of life. Ongoing research, advocacy efforts, and the availability of resources are vital in enhancing awareness and support for individuals living with these hypermobility disorders.

Research and Awareness

Ongoing studies and research on hypermobility spectrum disorder (HSD) and Ehlers-Danlos syndrome (EDS) are focused on improving diagnosis, understanding the underlying genetic factors, and developing targeted treatments, as outlined by the American Family Physician. This research aims to enhance the quality of life for individuals with these conditions and provide better management options.

Ongoing Studies

Numerous ongoing studies are dedicated to advancing the knowledge and understanding of HSD and EDS. These studies aim to explore various aspects of the disorders, including genetic factors, symptom management, and potential therapies. By participating in these studies, individuals with HSD and EDS have the opportunity to contribute to the advancement of medical knowledge and potentially benefit from new developments.

Advocacy and Resources

Several organizations and resources are available to support individuals with HSD and EDS, as well as raise awareness and promote research. These organizations offer a wealth of information, support services, and resources for affected individuals and their families. Some notable organizations include:

  • Ehlers-Danlos Society: A global organization dedicated to raising awareness, supporting research, and providing resources for individuals with hypermobile EDS and other types of Ehlers-Danlos syndrome. They offer educational materials, support groups, and information on clinical trials and research studies.
  • National Organization for Rare Disorders: Provides information and resources for individuals with hypermobile EDS and other rare disorders. They offer support services, educational materials, and a database of ongoing clinical trials and research studies.
  • Genetic and Rare Diseases Information Center: A resource provided by the National Institutes of Health (NIH) that offers information on hypermobile EDS and other rare genetic disorders. They provide educational materials, links to support groups, and information on ongoing research studies.
  • Hypermobility Syndromes Association: A UK-based charity that provides support, education, and advocacy for individuals with hypermobile EDS and other hypermobility syndromes. They offer resources, support groups, and information on research and clinical trials.
  • International Consortium on the Ehlers-Danlos Syndromes and Related Disorders: A collaborative network of researchers and healthcare professionals dedicated to advancing the understanding and treatment of Ehlers-Danlos syndrome and related disorders. They conduct research studies, share knowledge, and promote awareness and education.

These organizations play a crucial role in supporting individuals with HSD and EDS, as well as promoting research, awareness, and access to resources. Additionally, funding initiatives such as the Ehlers-Danlos Society Research Fund and the Rare Diseases Clinical Research Network contribute to scientific research and advancements in the field.

By staying informed and utilizing the resources provided by these organizations, individuals with HSD and EDS can access valuable support networks, educational materials, and potential opportunities to participate in research studies. This collaborative effort between researchers, healthcare professionals, and advocacy groups is crucial for furthering our understanding of these conditions and improving the lives of those affected.

References

[1]: https://www.aafp.org/pubs/afp/issues/2021/0415/p481.html

[2]: https://www.mayoclinic.org/diseases-conditions/ehlers-danlos-syndrome/diagnosis-treatment/drc-20362149

[3]: https://www.aafp.org/pubs/afp/issues/2021/0415/p481-s1.html

[4]: https://pubmed.ncbi.nlm.nih.gov/33856167/